RE:RE:RE:RE:RE:RE:Shareprice0.2% 1067 does not work as a skin lightener. That's why R+F is using it as a spot reducer. Maybe 0.4% 1067 will lighten skin.
"TFC1067 and 2% hydroquinone produced statistically significant skin lightening after 8 weeks of use, but only hydroquinone lightened the normal skin. This pattern continued into week 12 where both products significantly lightened dyschromic skin, but hydroquinone also lightened the normal skin, which is not always desirable." https://onlinelibrary.wiley.com/doi/10.1111/jocd.13771 MirrorWorldMan wrote: The 15 ml size tube for spot correction only is the real surprise. The price would be 6x higher if it was in 100ml sizes as we all thought initially upon signing of the R + F deal. Everyones prior estimate on tube sizes and sales relied on the assumption that 1067 was going to be used in larger tubes for overall lightening, not as a touch up. We can only hope that these end users start smearing across their entire face and see the results and order more smaller tubes, or a larger size is offered for general lightneing. The revised sales forcecasts based upon the smaller tube sizes may be why the share price is in the sewer post news. More partners in bigger markets for general skin lightening will propel things. Yes, this spot correction idea gets us used, we can only anticipate in leads to wider indication through its sales cycle.